Red blood cell transfusion to treat or prevent complications in sickle cell disease: An overview of Cochrane reviews

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 2, 2016, Pages

  Estcourt, Lise J ^a   Fortin, Patricia M ^a   Hopewell, Sally ^b   Trivella, Marialena ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; HEMOGLOBIN; HEMOGLOBIN S;

ALLOIMMUNIZATION; ANALGESIA; CLINICAL PROTOCOL; COCHRANE LIBRARY; DATA ANALYSIS; DATA COLLECTION METHOD; DATA EXTRACTION; DATA SYNTHESIS; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; EYE DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERRATER RELIABILITY; IRON OVERLOAD; KIDNEY DISEASE; LIVER DISEASE; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; RISK REDUCTION; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; THERAPY EFFECT;

EID: 84969492051     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012082     Document Type: Review

References (38)

1. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. New England Journal of Medicine 1998;339(1):5-11.
2. Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, et al. Fetal hemoglobin in sickle cell anemia. Blood 2011;118(1):19-27.
3. Alhashimi D, Fedorowickz Z, Alhashimi F, Dastgiri S. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007843.pub2]
4. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE Guidelines 3. rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6.
5. Cho G, Hambleton JR. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD008360.pub3]
6. Chou ST. Transfusion therapy for sickle cell disease: a balancing act. Hematology 2013;2013:439-46.
7. Chou ST, Jackson T, Vege S, Smith-Whiteley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122(6):1062-71.
8. Evidence Partners. DistillerSR: systematic review and literature review software. Ottawa: Evidence Partners, 2014.
9. US Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute Expert Panel Report 2014. Evidence-based management of sickle cell disease: Expert Panel Report, 2014. http://www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines (accessed 01 August 2015).
10. Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts and future promise. Journal of Clinical Investigation 2007;117(4):850-8.
11. Gravitz L, Pincock S. Sickle-cell disease. Nature 2014;515(7526):S1. [DOI: 10.1038/515S1a]
12. Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa. A neglected cause of early childhood mortality. American Journal of Preventive Medicine 2011;41(6S4):S398-S405.
13. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
14. Higgins JPT, Green S (editors). Chapter 22: Overviews of reviews. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
15. Hirst C, Williamson L. Preoperative blood transfusions for sickle cell disease. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD003149.pub2]
16. Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfusion Medicine Reviews 2007;21(2):118-32.
17. Kato GJ, McGowan V, Machado RF, Little JA, Morris CR, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006;107(6):2279-85.
18. Kato GJ, Hsieh M, Machado R, Taylor J 6th, Little J, Butman JA, et al. Cerebrovascular disease associated with sickle cell pulmonary hypertension. American Journal of Hematology 2006;81(7):503-10.
19. NICE (National Institute for Health and Care Excellence). Sickle cell disease. http://cks.nice.org.uk/sickle-cell-disease#!backgroundsub:3. London: NICE, (accessed 01 August 2015).
20. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2012;381(9861):142-51.
21. Pieper D, Buechter RB, Li L, Prediger B, Eikermann M. Systematic review found AMSTAR, but not R(evised)-AMSTAR to have good measurement properties. Journal of Clinical Epidemiology 2015;68:574-583.
22. Pleasants S. Epidemiology: a moving target. Nature 2014;515(7526):S2-3.
23. Porter J, Garbowski M. Consequences and management of iron overload in sickle cell disease. ASH Education Program Book 2013;1:447-56.
24. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010;376(9757):2018-31.
25. The Nordic Cochrane Centre. Review Manager (RevMan). Version Version 5.3. Copenhagen: The Cochrane Collaboration, 2014.
26. Rumaney MB, Ngo Bitoungui VJ, VorsterAA, Ramesar R, Kengne AP, Ngogang J, et al. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS ONE 2014;9(6):e100516.
27. Scheunemann LP, Ataga KI. Delayed hemolytic transfusion reaction in sickle cell disease. American Journal of the Medical Sciences 2010;339(3):266-9.
28. Schmalzer EA, Lee JO, Brown AK, Usami S, Chien S. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion. Transfusion 1987;27(3):228-33.
29. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
30. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007; Vol. 7, issue 10.
31. Sparkenbaugh E, Pawlinski R. Interplay between coagulation and vascular inflammation in sickle cell disease. British Journal of Haematology 2013;162(1):3-14.
32. Steinberg MH, Sebastini P. Genetic modifiers of sickle cell disease. American Journal of Hematology 2012;87(8):795-803.
33. Swerdlow PS. Red cell exchange in sickle cell disease. Hematology 2006;2006:48-53. [DOI: 10.1182/asheducation-2006.1.48]
34. Ubesie A, Emodi I, Ikefuna A, Ilechukwu G, Ilechukwu G. Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria. Annals of Medical and Health Sciences Research 2012;2(2):109-13.
35. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, et al. A comparison of conservative and aggressive transfusion regimes in the perioperative management of sickle cell disease. New England Journal of Medicine 1995;333(4):206-13.
36. Wagner MH, Berry RB. A patient with sickle cell disease and a low baseline sleeping oxygen saturation. Journal of Clinical Sleep Medicine 2007;3(3):313-5.
37. Wang WC, Dwan K. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD003146.pub2]
38. Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassel KL, James AH, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014;312(10):1033-48.